{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:07:21Z","timestamp":1769720841886,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12028-017-0392-9","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T15:48:24Z","timestamp":1490802504000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Probable Catastrophic Antiphospholipid Syndrome with Intracerebral Hemorrhage Secondary to Epstein\u2013Barr Viral Infection"],"prefix":"10.1007","volume":"28","author":[{"given":"Mark P.","family":"Plummer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M. H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell S.","family":"Damian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lavinio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"issue":"2","key":"392_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"392_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R, Rodriguez-Pinto I, Colafrancesco S, et al. 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. Autoimmun Rev. 2014;13(7):699\u2013707.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"392_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.autrev.2006.06.013","volume":"6","author":"D Erkan","year":"2006","unstructured":"Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006;6(2):98\u2013103.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"392_CR4","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992;19(4):508\u201312.","journal-title":"J Rheumatol"},{"issue":"12","key":"392_CR5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","volume":"15","author":"I Rodriguez-Pinto","year":"2016","unstructured":"Rodriguez-Pinto I, Moitinho M, Santacreu I, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev. 2016;15(12):1120\u20134.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"392_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2008.10.003","volume":"32","author":"OD Ortega-Hernandez","year":"2009","unstructured":"Ortega-Hernandez OD, Agmon-Levin N, Blank M, et al. The physiopathology of the catastrophic antiphospholipid (Asherson\u2019s) syndrome: compelling evidence. J Autoimmun. 2009;32(1):1\u20136.","journal-title":"J Autoimmun"},{"issue":"11","key":"392_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/0961203306071004","volume":"15","author":"Y Levy","year":"2006","unstructured":"Levy Y, Almog O, Gorshtein A, et al. The environment and antiphospholipid syndrome. Lupus. 2006;15(11):784\u201390.","journal-title":"Lupus"},{"issue":"2","key":"392_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.autrev.2006.06.006","volume":"6","author":"G Espinosa","year":"2006","unstructured":"Espinosa G, Bucciarelli S, Cervera R, et al. Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2006;6(2):68\u201371.","journal-title":"Autoimmun Rev"},{"issue":"14","key":"392_CR9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/0961203316640912","volume":"25","author":"N Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, et al. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus. 2016;25(14):1520\u201331.","journal-title":"Lupus"},{"issue":"11","key":"392_CR10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","volume":"14","author":"M Garcia-Carrasco","year":"2015","unstructured":"Garcia-Carrasco M, Mendoza-Pinto C, Macias-Diaz S, et al. The role of infectious diseases in the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2015;14(11):1066\u201371.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"392_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2006.06.007","volume":"6","author":"S Bucciarelli","year":"2006","unstructured":"Bucciarelli S, Cervera R, Espinosa G, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev. 2006;6(2):72\u20135.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"392_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-200204000-00007","volume":"30","author":"C Wenzel","year":"2002","unstructured":"Wenzel C, Stoiser B, Locker GJ, et al. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med. 2002;30(4):763\u201370.","journal-title":"Crit Care Med"},{"issue":"2","key":"392_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ijlh.12138","volume":"36","author":"ME Martinuzzo","year":"2014","unstructured":"Martinuzzo ME, Barrera LH, Da MA, et al. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin. Int J Lab Hematol. 2014;36(2):144\u201350.","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"392_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11926-014-0482-z","volume":"17","author":"I Rodriguez-Pinto","year":"2015","unstructured":"Rodriguez-Pinto I, Espinosa G, Cervera R. Catastrophic APS in the context of other thrombotic microangiopathies. Curr Rheumatol Rep. 2015;17(1):482.","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"392_CR15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589\u2013600.","journal-title":"N Engl J Med"},{"issue":"3","key":"392_CR16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/BOR.0000000000000269","volume":"28","author":"NM Kazzaz","year":"2016","unstructured":"Kazzaz NM, McCune WJ, Knight JS. Treatment of catastrophic antiphospholipid syndrome. Curr Opin Rheumatol. 2016;28(3):218\u201327.","journal-title":"Curr Opin Rheumatol"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-017-0392-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-017-0392-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-017-0392-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T17:27:48Z","timestamp":1519147668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-017-0392-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s12028-017-0392-9","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}